220 related articles for article (PubMed ID: 35956844)
21. Dietary quinoa (Chenopodium quinoa Willd.) polysaccharides ameliorate high-fat diet-induced hyperlipidemia and modulate gut microbiota.
Cao Y; Zou L; Li W; Song Y; Zhao G; Hu Y
Int J Biol Macromol; 2020 Nov; 163():55-65. PubMed ID: 32615219
[TBL] [Abstract][Full Text] [Related]
22. Fabrication of chitosan-coated epigallocatechin-3-gallate (EGCG)-hordein nanoparticles and their transcellular permeability in Caco-2/HT29 cocultures.
Song H; He A; Guan X; Chen Z; Bao Y; Huang K
Int J Biol Macromol; 2022 Jan; 196():144-150. PubMed ID: 34914913
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats.
Li W; Zhu C; Liu T; Zhang W; Liu X; Li P; Zhu T
Diab Vasc Dis Res; 2020; 17(6):1479164120966998. PubMed ID: 33280417
[TBL] [Abstract][Full Text] [Related]
24. Preparation of β-lactoglobulin/gum arabic complex nanoparticles for encapsulation and controlled release of EGCG in simulated gastrointestinal digestion model.
Gao J; Mao Y; Xiang C; Cao M; Ren G; Wang K; Ma X; Wu D; Xie H
Food Chem; 2021 Aug; 354():129516. PubMed ID: 33744663
[TBL] [Abstract][Full Text] [Related]
25. Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats.
Zhang G; Zhang J
Drug Des Devel Ther; 2018; 12():2509-2518. PubMed ID: 30147298
[TBL] [Abstract][Full Text] [Related]
26. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.
Fang W; Peng ZL; Dai YJ; Wang DL; Huang P; Huang HP
Drug Deliv; 2019 Dec; 26(1):1058-1067. PubMed ID: 31735064
[TBL] [Abstract][Full Text] [Related]
27. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
28. Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: Formulation, in vitro and in vivo evaluation.
Omari-Siaw E; Zhu Y; Wang H; Peng W; Firempong CK; Wang YW; Cao X; Deng W; Yu J; Xu X
Eur J Pharm Sci; 2016 Mar; 85():112-22. PubMed ID: 26851382
[TBL] [Abstract][Full Text] [Related]
29. Oryzanol Attenuates High Fat and Cholesterol Diet-Induced Hyperlipidemia by Regulating the Gut Microbiome and Amino Acid Metabolism.
Yan S; Chen J; Zhu L; Guo T; Qin D; Hu Z; Han S; Zhou Y; Akan OD; Wang J; Luo F; Lin Q
J Agric Food Chem; 2022 Jun; 70(21):6429-6443. PubMed ID: 35587527
[TBL] [Abstract][Full Text] [Related]
30. Effect of epigallocatechin gallate on the gelatinisation and retrogradation of wheat starch.
Pan J; Li M; Zhang S; Jiang Y; Lv Y; Liu J; Liu Q; Zhu Y; Zhang H
Food Chem; 2019 Oct; 294():209-215. PubMed ID: 31126455
[TBL] [Abstract][Full Text] [Related]
31. Extraction of Epigallocatechin Gallate and Epicatechin Gallate from Tea Leaves Using β-Cyclodextrin.
Cui L; Liu Y; Liu T; Yuan Y; Yue T; Cai R; Wang Z
J Food Sci; 2017 Feb; 82(2):394-400. PubMed ID: 28071811
[TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-α signaling in the pancreas of rats on a high-fat diet.
Cao Y; Bao S; Yang W; Zhang J; Li L; Shan Z; Teng W
Nutr Res; 2014 Dec; 34(12):1066-74. PubMed ID: 25453543
[TBL] [Abstract][Full Text] [Related]
33. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.
Kübeck R; Bonet-Ripoll C; Hoffmann C; Walker A; Müller VM; Schüppel VL; Lagkouvardos I; Scholz B; Engel KH; Daniel H; Schmitt-Kopplin P; Haller D; Clavel T; Klingenspor M
Mol Metab; 2016 Dec; 5(12):1162-1174. PubMed ID: 27900259
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
Zhang L; Chen W; Tu G; Chen X; Lu Y; Wu L; Zheng D
Int J Nanomedicine; 2020; 15():4417-4429. PubMed ID: 32606686
[TBL] [Abstract][Full Text] [Related]
35. Nano-enabled delivery of EGCG ameliorates silica-induced pulmonary fibrosis in rats.
Yao JJ; Ma QQ; Shen WW; Li LC; Hu D
Toxicology; 2022 Mar; 469():153114. PubMed ID: 35114310
[TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin gallate alleviated the in vivo toxicity of ZnO nanoparticles to mouse intestine.
Wang C; Huang C; Cao Y
J Appl Toxicol; 2024 May; 44(5):686-698. PubMed ID: 38095138
[TBL] [Abstract][Full Text] [Related]
37. Co-encapsulation of Epigallocatechin Gallate (EGCG) and Curcumin by Two Proteins-Based Nanoparticles: Role of EGCG.
Yan X; Zhang X; McClements DJ; Zou L; Liu X; Liu F
J Agric Food Chem; 2019 Dec; 67(48):13228-13236. PubMed ID: 31610115
[TBL] [Abstract][Full Text] [Related]
38. Preservation of (-)-epigallocatechin-3-gallate antioxidant properties loaded in heat treated β-lactoglobulin nanoparticles.
Li B; Du W; Jin J; Du Q
J Agric Food Chem; 2012 Apr; 60(13):3477-84. PubMed ID: 22409289
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women.
Most J; Penders J; Lucchesi M; Goossens GH; Blaak EE
Eur J Clin Nutr; 2017 Sep; 71(9):1040-1045. PubMed ID: 28589947
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous loading of (-)-epigallocatechin gallate and ferulic acid in chitosan-based nanoparticles as effective antioxidant and potential skin-whitening agents.
Li G; Lee YY; Lu X; Chen J; Liu N; Qiu C; Wang Y
Int J Biol Macromol; 2022 Oct; 219():333-345. PubMed ID: 35934077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
